The forecasted hospital discharges for malignant neoplasm of the prostate in France from 2024 to 2028 indicate a steady increase, ranging from 106.8 to 108.2 units per hundred thousand persons. This suggests an incremental annual growth rate, pointing towards a moderate rise in hospital discharges related to prostate cancer. Unfortunately, the data for 2023 has not been provided; thus, year-on-year variation percentages cannot be accurately calculated without previous figures from 2022 and earlier.

Future trends to watch for:

Advancements in medical treatments and early detection methods could impact discharge rates, potentially decreasing the hospitalization necessity.
Demographic changes, such as an aging population, may contribute to increased cases and discharges.
Healthcare policy changes in France, aiming to reduce hospitalization, could influence these numbers positively by promoting outpatient care and prevention practices.